Keely S J, Barrett K E
Department of Medicine, University of California, San Diego, California 92103, USA.
J Biol Chem. 1999 Nov 19;274(47):33449-54. doi: 10.1074/jbc.274.47.33449.
We have previously demonstrated that epidermal growth factor (EGF) inhibits calcium-dependent chloride secretion via a mechanism involving stimulation of phosphatidylinositol 3-kinase (PI3-K). The muscarinic agonist of chloride secretion, carbachol (CCh), also stimulates an antisecretory pathway that involves transactivation of the EGF receptor (EGFR) but does not involve PI3-K. Here, we have examined if ErbB receptors, other than the EGFR, have a role in regulation of colonic secretion and if differential effects on ErbB receptor activation may explain the ability of the EGFR to propagate diverse signaling pathways in response to EGF versus CCh. Basolateral, but not apical, addition of the ErbB3/ErbB4 ligand alpha-heregulin (HRG; 1-100 ng/ml) inhibited secretory responses to CCh (100 microM) across voltage-clamped T(84) epithelial cells. Immunoprecipitation/Western blot studies revealed that HRG (100 ng/ml) stimulated tyrosine phosphorylation and dimerization of ErbB3 and ErbB2, but had no effect on phosphorylation of the EGFR. HRG also stimulated recruitment of the p85 subunit of PI3-K to ErbB3/ErbB2 receptor dimers, while the PI3-K inhibitor, wortmannin (50 nM), completely reversed the inhibitory effect of HRG on CCh-stimulated secretion. Further studies revealed that, while both EGF (100 ng/ml) and CCh (100 microM) stimulated phosphorylation of the EGFR, only EGF stimulated phosphorylation of ErbB2, and neither stimulated ErbB3 phosphorylation. EGF, but not CCh, stimulated the formation of EGFR/ErbB2 receptor dimers and the recruitment of p85 to ErbB2. We conclude that ErbB2 and ErbB3 are expressed in T(84) cells and are functionally coupled to inhibition of calcium-dependent chloride secretion. Differential dimerization with other ErbB family members may underlie the ability of the EGFR to propagate diverse inhibitory signals in response to activation by EGF or transactivation by CCh.
我们之前已经证明,表皮生长因子(EGF)通过一种涉及刺激磷脂酰肌醇3激酶(PI3-K)的机制来抑制钙依赖性氯化物分泌。氯化物分泌的毒蕈碱激动剂卡巴胆碱(CCh)也会刺激一条抗分泌途径,该途径涉及表皮生长因子受体(EGFR)的反式激活,但不涉及PI3-K。在此,我们研究了除EGFR之外的ErbB受体是否在结肠分泌调节中发挥作用,以及对ErbB受体激活的不同影响是否可以解释EGFR响应EGF与CCh时传播不同信号通路的能力。在电压钳制的T(84)上皮细胞中,从基底外侧而非顶端添加ErbB3/ErbB4配体α-神经调节蛋白(HRG;1 - 100 ng/ml)可抑制对CCh(100 μM)的分泌反应。免疫沉淀/蛋白质印迹研究表明,HRG(100 ng/ml)刺激了ErbB3和ErbB2的酪氨酸磷酸化和二聚化,但对EGFR的磷酸化没有影响。HRG还刺激了PI3-K的p85亚基募集到ErbB3/ErbB2受体二聚体上,而PI3-K抑制剂渥曼青霉素(50 nM)完全逆转了HRG对CCh刺激分泌的抑制作用。进一步的研究表明,虽然EGF(100 ng/ml)和CCh(100 μM)都刺激了EGFR的磷酸化,但只有EGF刺激了ErbB2的磷酸化,且两者均未刺激ErbB3的磷酸化。EGF而非CCh刺激了EGFR/ErbB2受体二聚体的形成以及p85募集到ErbB2上。我们得出结论,ErbB2和ErbB3在T(84)细胞中表达,并且在功能上与抑制钙依赖性氯化物分泌相关联。与其他ErbB家族成员的不同二聚化可能是EGFR响应EGF激活或CCh反式激活而传播不同抑制信号能力的基础。